IBIO iBio Inc

-0.01 (-3.23%)
Sep 25 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Company Name Stock Ticker Symbol Market Type
iBio Inc IBIO AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -3.23% 0.30 19:55:32
Open Price Low Price High Price Close Price Prev Close
0.3101 0.2916 0.3204 0.2975 0.31
more quote information »

Recent News

Date Time Source Heading
9/21/202316:05GLOBEiBio Announces Amendment to Credit Agreement with Woodforest
9/21/202308:00EDGAR2Form 8-K - Current report
8/30/202316:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/24/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/24/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202316:02EDGAR2Form D - Notice of Exempt Offering of Securities
8/14/202316:15GLOBEiBio Reports Triple Milestone: In Vivo Proof-of-Concept for..
8/14/202315:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/07/202316:01EDGAR2Form 8-K - Current report
8/07/202309:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/04/202316:47EDGAR2Form 8-K - Current report
7/28/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/13/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/10/202308:29EDGAR2Form 8-K - Current report
6/27/202308:00GLOBEiBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO..
6/12/202316:15GLOBEiBio Forges Research Collaboration with the National..
6/06/202308:00GLOBEiBio Expands Tech Stack with EngageTx™; Adds TROP-2..
5/09/202316:30GLOBEiBio to Participate in the JMP Securities Life Sciences..
4/04/202316:05GLOBEiBio Discovers New Panel of CD3 T-Cell Binding Antibodies..
3/31/202308:10GLOBEiBio Advances Anti-CCR8 Antibody Program to Preclinical In..
2/16/202316:47GLOBEiBio Announces MUC16 as its Latest Immune-Oncology Target..
1/05/202308:00GLOBEiBio Announces Issuance of U.S. Patent Covering..
12/09/202216:05GLOBEiBio Announces Closing of $3.5 Million Underwritten Public..
12/06/202223:27GLOBEiBio Announces Pricing of $3.5 Million Underwritten Public..
12/06/202216:01GLOBEiBio Announces Proposed Underwritten Public Offering
12/06/202208:00GLOBEiBio to Participate in the JMP Securities Hematology and..
12/05/202208:00GLOBEiBio® to Showcase the RubrYc® Discovery Engine During Poster..
12/02/202216:30GLOBEiBio Announces CEO Departure
11/03/202208:00GLOBEiBio Accelerates Transformation to AI-Powered Biotech
9/28/202200:25TRMNIbio (IBIO) Receives a Buy from JMP Securities
9/27/202216:10GLOBEiBio Reports Preliminary Unaudited Fiscal Year 2022..